Penrose Therapeutx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
BioSpace Movers & Shakers, Nov 19
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Published: May 13, 2021 By Alex Keown
Akouos, Inc. – Kathy Reape was named chief development officer of Boston-based Akouos. Reape most recently served as chief medical officer at Spark Therapeutics where she oversaw clinical development, pharmacovigilance, and medical affairs activities. Reape was a key member of the team responsible for the development and commercialization of Luxturna, the first FDA-approved in vivo gene therapy approved for an inherited retinal disease caused by mutations in both copies of the RPE65 gene. Prior to Spark, Reape was senior vice president of clinical development focusing on global brands research and development at Allergan and Actavis.
CARMAT – France-based CARMAT’s board of directors is reorganizing its governance and appointed three new directors. The company tapped Florent Battistella, David Coti and John B. Hernandez as directors. Battistella founded Nisima, a holding company, which holds stakes in various firms, notably
Search jobs 11-May-2021 CORRECTING and REPLACING Former FDA and NIH Leader Dr. Vicki Seyfert-Margolis Joins Penrose TherapeuTx Scientific Advisory Board
Penrose scientific advisory board includes prominent research and regulatory experts in oncology, immunology and mitochondrial science
ANN ARBOR, Mich. & CHICAGO (BUSINESS WIRE) Please replace the release with the following corrected version due to multiple revisions in the first and third paragraphs, as well as correcting all instances of MyOwnMed to My Own Med, Inc. in the release text and image caption.
The corrected release reads:
FORMER FDA AND NIH LEADER DR. VICKI SEYFERT-MARGOLIS JOINS PENROSE THERAPEUTX SCIENTIFIC ADVISORY BOARD
Penrose scientific advisory board includes prominent research and regulatory experts in oncology, immunology and mitochondrial science
BioSpace Movers & Shakers, April 9
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Published: Apr 09, 2021 By Alex Keown
Atara Biotherapeutics – Amie Krause was named Senior Vice President and Chief People Officer at Atara Biotherapeutics. In this role, Krause will be tasked with building a company culture that “rewards” values through actions and results. Prior to her tenure with Atara, Krause held several HR leadership positions at Amgen, including her role as Global HR Lead, Organizational Effectiveness during which she served as the human resources lead for Amgen’s global commercial operations covering the Americas, Europe, Asia, and the Middle East.
PsyBio Therapeutics – Michael Spigarelli was named chief medical officer of Ohio-based PsyBio. Before PsyBio Therapeutics, Spigarelli served as CMOr for Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases. Prior to that, he served as Vice President of Medical Affairs for Immucor, Inc., a leading provider of transfusion and tran
vimarsana © 2020. All Rights Reserved.